Sequence of I23O1_MOUSE
EC Number:1.13.11.52
EC Number
Recommended Name
Accession Code
Organism
No of amino acids
Molecular Weight [Da]
Source
Reaction
D-tryptophan + O2 = N-formyl-D-kynurenine
General information:
Sequence
0 MALSKISPTE GSRRILEDHH IDEDVGFALP HPLVELPDAY SPWVLVARNL PVLIENGQLR
60 EEVEKLPTLS TDGLRGHRLQ RLAHLALGYI TMAYVWNRGD DDVRKVLPRN IAVPYCELSE
120 KLGLPPILSY ADCVLANWKK KDPNGPMTYE NMDILFSFPG GDCDKGFFLV SLLVEIAASP
180 AIKAIPTVSS AVERQDLKAL EKALHDIATS LEKAKEIFKR MRDFVDPDTF FHVLRIYLSG
240 WKCSSKLPEG LLYEGVWDTP KMFSGGSAGQ SSIFQSLDVL LGIKHEAGKE SPAEFLQEMR
300 EYMPPAHRNF LFFLESAPPV REFVISRHNE DLTKAYNECV NGLVSVRKFH LAIVDTYIMK
360 PSKKKPTDGD KSEEPSNVES RGTGGTNPMT FLRSVKDTTE KALLSWP
Download this sequence
Download all sequences for 1.13.11.52
Sequence related references
Sequence Reference
Authors
Title
Journal
Volume
Pages
Year
PubMed ID
487050
Habara-Ohkubo A.,Takikawa O.,Yoshida R.
Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase.
Gene
105
221-227
1991
487051
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Genome Res.
14
2121-2127
2004
487052
Baban B.,Chandler P.,McCool D.,Marshall B.,Munn D.H.,Mellor A.L.
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific.
J. Reprod. Immunol.
61
67-77
2004
487053
Yuasa H.J.,Takubo M.,Takahashi A.,Hasegawa T.,Noma H.,Suzuki T.
Evolution of vertebrate indoleamine 2,3-dioxygenases.
J. Mol. Evol.
65
705-714
2007
487054
de Faudeur G.,de Trez C.,Muraille E.,Leo O.
Normal development and function of dendritic cells in mice lacking IDO-1 expression.
Immunol. Lett.
118
21-29
2008
487055
Dai X.,Zhu B.T.
Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions.
J. Histochem. Cytochem.
58
17-28
2010
487056
Chang M.Y.,Smith C.,DuHadaway J.B.,Pyle J.R.,Boulden J.,Soler A.P.,Muller A.J.,Laury-Kleintop L.D.,Prendergast G.C.
Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase.
Cancer Biol. Ther.
12
1050-1058
2011
487057
van Baren N.,Van den Eynde B.J.
Tryptophan-degrading enzymes in tumoral immune resistance.
Front. Immunol.
6
34-34
2015
in fasta format
in fasta format
in csv (Excel, OpenOffice) format


